The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 07, 2018
Filed:
Sep. 13, 2013
Applicant:
British Columbia Cancer Agency Branch, Vancouver, CA;
Inventors:
Kuo-shyan Lin, Surrey, CA;
Francois Benard, Vancouver, CA;
Jinhe Pan, Vancouver, CA;
Felix Mesak, Irvine, CA (US);
Zhengxing Zhang, Vancouver, CA;
Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/435 (2006.01); A61K 31/496 (2006.01); A61K 31/498 (2006.01); A61K 38/08 (2006.01); A61K 51/08 (2006.01); C07K 7/18 (2006.01); C07D 241/50 (2006.01); C07D 241/04 (2006.01); C07D 403/04 (2006.01); A61K 38/04 (2006.01); C07D 403/12 (2006.01); A61K 51/04 (2006.01);
U.S. Cl.
CPC ...
A61K 51/088 (2013.01); A61K 31/435 (2013.01); A61K 31/496 (2013.01); A61K 31/498 (2013.01); A61K 38/043 (2013.01); A61K 51/0455 (2013.01); A61K 51/0459 (2013.01); C07D 241/04 (2013.01); C07D 241/50 (2013.01); C07D 403/04 (2013.01); C07D 403/12 (2013.01); C07K 7/18 (2013.01);
Abstract
Bradykinin B1 receptor (B1R) targeting peptides and compounds are radiolabelled with radioisotopes that are suitable for imaging and/or radiotherapy. The radiolabelled peptides and compounds have utility in imaging tissues expressing or overexpressing B1R and/or treating diseases or conditions in which B1R is expressed or overexpressed, including cancer.